Metabolic Dysfunction-associated Steatohepatitis
📧 Sign up to get email alerts when something new happens for Metabolic Dysfunction-associated Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-05-15Clinical Trial Update: A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH [Phase 3]
Phase 3 study evaluating denifanstat for metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associat…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)
This clinical trial update describes the LOVE study's long-term follow-up to determine outcomes in MASLD/MASH and related steatotic liver di…
-
EMA other · 2025-03-20EMA qualifies first artificial intelligence tool to diagnose inflammatory liver disease (MASH) in biopsy samples
EMA announces it has qualified the first artificial intelligence tool to diagnose metabolic dysfunction-associated steatohepatitis (MASH) in…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) [Phase 2]
Phase 2 trial update: ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis/nonalcoholic steatohepatitis …
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Clinical Classification of MAFLD Based Liver Biopsy
This clinical trial registry entry describes a study on classifying MAFLD using liver biopsy and notes that it is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH
A clinical trial evaluating prognostic factors for hepatocellular carcinoma and liver transplantation in patients with MASLD/MASH; recruitme…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) [NA]
A clinical trial update focusing on characterizing and managing metabolic dysfunction-associated fatty liver disease (MAFLD) and its associa…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 study of TVB-2640 in MASLD/MASH/NASH has completed with results posted.
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
This document provides an update on the development of new non-invasive biomarkers for metabolic dysfunction-associated steatotic liver dise…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups. [EARLY_Phase 1]
Early-phase microdose clinical trial evaluating binding of the radiotracer [68Ga]Ga-DOTA-CYS-ATH001 in healthy volunteers and patients with …
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Global Research Initiative for Patients Screening on MASH
A clinical trial update shows recruitment is ongoing for the Global Research Initiative for Patients Screening on MASH, enrolling participan…
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Activity [NA]
A clinical trial update describing a new approach to engage patients with steatotic liver disease in physical activity; the study is not yet…